emerging sachrp issues

23
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of Veterans Affairs October 17, 2005

Upload: badu

Post on 25-Jan-2016

47 views

Category:

Documents


0 download

DESCRIPTION

Emerging SACHRP Issues. K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of Veterans Affairs October 17, 2005. SACHRP. Secretary’s Advisory Committee on Human Research Protection, HHS* Purpose - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Emerging SACHRP Issues

Emerging SACHRP Issues

K. Lynn Cates, MDAssistant Chief Research & Development OfficerDirector, PRIDEOffice of Research & DevelopmentDepartment of Veterans AffairsOctober 17, 2005

Page 2: Emerging SACHRP Issues

SACHRP• Secretary’s Advisory Committee on Human

Research Protection, HHS*

• Purpose• To provide expert advice &

recommendations to the Secretary of HHS & the Assistant Secretary for Health on issues and topics pertaining to or associated with the protection of human research subjects.

*Authority: 42 U.S.C. 217a, section 222, PHS Act

Page 3: Emerging SACHRP Issues

Emerging SACHRP Issues

• Federal Adverse Events Taskforce (FAET)

• IRB Workshop

Page 4: Emerging SACHRP Issues

Federal Adverse Event Taskforce

• Charge• Propose specific means for promoting

harmonized and streamlined federal requirements for reporting, analyzing, and communicating adverse events in clinical research.

Page 5: Emerging SACHRP Issues

Federal Adverse Event Taskforce• Member Agencies

• AHRQ• CDC• DoD• FDA• OHRP• NIH• VA

Page 6: Emerging SACHRP Issues

Federal Adverse Events Taskforce

• Objectives1. Common terms & definitions2. Common AE report forms3. Common workflow patterns4. Communications

Page 7: Emerging SACHRP Issues

1. Common Terms & Definitions

• Reduce variability in language• e.g., “unanticipated problem” vs. “adverse

event” or “unanticipated” vs. “unexpected”

• Align federal agencies’ policies & guidance

Page 8: Emerging SACHRP Issues

2. Common AE Report Forms

• Basal Adverse Event Report (BAER)• Develop a baseline set of core information

adopted by all agencies

• Address individual agency needs by adding extra fields

Page 9: Emerging SACHRP Issues

3. Common Workflow Patterns

• Develop a best practices blue print for reporting, analyzing, and applying AE data

Page 10: Emerging SACHRP Issues

AE Reporting in Multi-Center Clinical Trials: Trans-Federal Guidance

• Clarify regulatory requirements for reporting and reviewing adverse events from multi-center trials

• Outline criteria for when AE reports should be forwarded to other sites

• Work with industry and academia

Page 11: Emerging SACHRP Issues

4. Communication

• Effective communication• Enhance subjects’ safety• Further scientific knowledge• Earn public trust

Page 12: Emerging SACHRP Issues

FAET Focus Groups

• Examine current practices at the local level• What safety information does an IRB receive

and when?• How is the safety information analyzed?• How and to whom is it communicated?

• Identify Problem Areas• Does government contribute?

• Define what needs to be done

Page 13: Emerging SACHRP Issues

VA Local Management of Adverse Events:Mission

• Ensure that local management of unanticipated problems in research, including adverse events, assures maximal protection for VA research participants, and complies fully with all laws, regulations, and standards.

Page 14: Emerging SACHRP Issues

VA Local Management of Adverse Events:Charge

• Identifying/Reporting• What should be reported?• When should it be reported?• Where should it be reported?

• Monitoring• Who monitors?• What is monitored?• What trends/patterns require further

action?

Page 15: Emerging SACHRP Issues

VA Local Management of Adverse Events:Charge

• Research v. Patient Safety• Corrective Action

• Who takes action?• What are appropriate actions?• When does it become research

misconduct?

Page 16: Emerging SACHRP Issues

Alternatives to Current IRBs

• IRB Workshop

• VA Central IRB

• “What is Research?” Panel

Page 17: Emerging SACHRP Issues

IRB Workshop

• Steering Group• OHRP• NIH• AAMC• ASCO• VA

• November 17-18, 2005, Washington, DC

Page 18: Emerging SACHRP Issues

IRB Workshop

• Invitational, exploratory meeting

• Diverse perspectives• IRBs• Academic and community-based investigators• Attorneys• Patients• Ethicists• Industry officials• Senior university and medical school research

administrators

Page 19: Emerging SACHRP Issues

IRB Workshop Topics

• Institutional responsibilities

• Ways to reduce burdens (especially for multi-site trials)

• Costs and other barriers

• The federal policy framework relevant to new IRB arrangements

Page 20: Emerging SACHRP Issues

IRB Workshop: Follow-on Activities

• Report for SACHRP on• The suitability of alternative models of

IRB review for different research contexts

• Strategies to address barriers

• Public meeting

Page 21: Emerging SACHRP Issues

VA Central IRB

• Review multi-site VA studies

• Assure quality by ensuring appropriate representation (scientific, ethical, “community”)

• Enhance efficiency

Page 22: Emerging SACHRP Issues

VA Central IRB:Timeline

Fall 2005• Implementation strategies Policies & procedures• Begin recruitment process for IRB Administrator• Site visits to NCI CIRB, Western & Chesapeake

Winter 2005-6• IRB Chair and field input

Summer & Fall 2006• Training – local accountability

Page 23: Emerging SACHRP Issues

Alternatives to Current IRB System“What is Research?” Panel

• Responsibilities• Review multi-site projects to determine

whether or not they are “research”• Develop guidance for the field on “What

is Research?” (vs. Quality)

• High level representatives from ORD, ORO, Ethics, Patient Services, Quality